NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 7.2025

The NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) provide recommendations for the treatment of NSCLC. These NCCN Guidelines Insights discuss recent updates to the NCCN Guidelines, with a focus on systemic therapy options for the treatment of patients with nonmetastatic NSCLC and the corresponding molecular testing considerations.

Authors

Institutions

Publication Details

Journal
Journal of the National Comprehensive Cancer Network
Published
2025-09-01
DOI
https://doi.org/10.6004/jnccn.2025.0043
Citations
21
Primary Topic
Lung Cancer Treatments and Mutations
Type
article
Field-Weighted Citation Impact
31.89
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 7.2025

Jane Yanagawa, Dawn Owen, Jules Lin, Thomas Ng et al.
21 citations
Journal of the National Comprehensive Cancer Network
Lung Cancer Treatments and Mutations
31.89
article

NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 7.2025

Jane Yanagawa, Dawn Owen, Jules Lin, Thomas Ng, Joe Y. Chang, Andrea L. Axtell, Billy W. Loo, Jessica R. Bauman, Rudy P. Lackner, Tawee Tanvetyanon, Tejas Patil, Fabien Maldonado, Ankit Bharat, Daniel Morgensztern, Ana Lucia Ruano Mendez, Patricio Marcelo Polanco, Travis E. Grotz, Trey C. Mullikin, Douglas E. Wood, Dara L. Aisner, Matthew A. Gubens, Gregory J. Riely, Lisa Hang, Michael Lanuti, Alda L. Tam, Sandip Pravin Patel, Scott Gettinger, Christine M. Lovly, Edwin H. Yau, Theresa A. Shapiro, Aakash Desai, Jonathan Wesley Riess, Thomas J. Dilling, Dwight Hall Owen, Jonathan E. Dowell, Aditi P. Singh, Gregory A. Durm, Benjamin Levy, Kristina M. Gregory, James P. Stevenson, Aditya Juloori
article en
21 citations

Abstract

The NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) provide recommendations for the treatment of NSCLC. These NCCN Guidelines Insights discuss recent updates to the NCCN Guidelines, with a focus on systemic therapy options for the treatment of patients with nonmetastatic NSCLC and the corresponding molecular testing considerations.

Journal of the National Comprehensive Cancer NetworkVol. 23(9)
Fox Chase Cancer Center (US), Roswell Park Comprehensive Cancer Center (US), Barnes-Jewish Hospital (US), Cleveland Clinic (US), Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa (ZA), Memorial Sloan Kettering Cancer Center (US), The University of Texas MD Anderson Cancer Center (US), University of Tennessee Health Science Center (US), Breast Cancer Research Foundation (US), University of Utah (US), The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (US), UC San Diego Health System (US), Huntsman Cancer Institute (US), Cancer Institute (WIA) (IN), Susan Thompson Buffett Foundation (US), WinnMed (US), Yale Cancer Center (US), Moffitt Cancer Center (US), Massachusetts General Hospital (US), Fred Hutch Cancer Center (US), Southwestern Medical Center (US), Jewish Hospital (US), University of Wisconsin Carbone Cancer Center (US), Sidney Kimmel Cancer Center (US), University Hospitals Seidman Cancer Center (US), Duke Medical Center (US), University of Colorado Cancer Center (US), Smilow Cancer Hospital (US), UCSF Helen Diller Family Comprehensive Cancer Center (US), Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Moores Cancer Center, University of Chicago Medicine Comprehensive Cancer Center, UCLA Jonsson Comprehensive Cancer Center, Vanderbilt-Ingram Cancer Center, Stanford Cancer Institute, Duke Cancer Institute, Fred and Pamela Buffett Cancer Center, UC Davis Comprehensive Cancer Center, Harold C. Simmons Comprehensive Cancer Center, O'Neal Comprehensive Cancer Center, National Comprehensive Cancer Network, Indiana University (US), University of Pennsylvania (US), University of California, Davis (US), The University of Texas Southwestern Medical Center (US), University of Colorado Denver (US)
Openalex Percentile: Top 0%
Lung Cancer Treatments and Mutations
31.89
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.